Search results
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 13 hours agoNovavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion... Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 4 days agoNovavax has a sole license to its adjuvanted C
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine ...
WFRV 5 Green Bay· 4 days ago...include: a co-exclusive license to co-commercialize Novavax's current stand-alone adjuvanted COVID-19 vaccine worldwide (except in countries with existing Advance Purchase Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 17 hours agoNovavax's Covid-19 vaccine is authorized in select geographies under trade names Novavax Covid-19 Vaccine, Adjuvanted; Covovax; and Nuvaxovid ...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
CBS 47 Fresno· 4 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new ...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 4 days agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 4 days agoThe licensing agreement will allow Novavax to lift its "going concern" warning, which it first...
French, US drug firms team up for Covid-flu shot
Medical Xpress· 4 days agoNovavax announced Friday an alliance to sell a COVID vaccineand develop another that combines with a flu shot. Under a licensing deal worth up to $1.2...
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation
The Conversation· 6 days agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU announcement was preceded by an application from AstraZeneca on March 27 2024 to withdraw the EU ...
Dow Jones and S&P 500 open higher after strong week; rate cut optimism grows
Proactive Investors· 4 days agoAll three indexes rose around 0.2% at the sound of the opening bell, with the Dow Jones at 39,479,...